Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection.
A 14-year-old girl with perinatally acquired human immunodeficiency virus infection had fatal intravascular hemolysis after intravenous administration of ceftriaxone. Laboratory studies confirmed the presence of an antibody against ceftriaxone in the serum and on the patient's red blood cells. No evidence of sepsis, glucose-6-phosphate dehydrogenase deficiency or anaphylaxis was found.
Moallem
H J
HJ
Department of Pediatrics Health Science Center of State University of New York at Brooklyn 11203, USA.
Garratty
G
G
Wakeham
M
M
Dial
S
S
Oligario
A
A
Gondi
A
A
Rao
S P
SP
Fikrig
S
S
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000276:immunology; D000293:Adolescent; D000743:Anemia, Hemolytic / Q000139:chemically induced* / Q000276:immunology; D000906:Antibodies; D002443:Ceftriaxone / Q000009:adverse effects* / Q000276:immunology; D002511:Cephalosporins / Q000009:adverse effects* / Q000276:immunology; D017809:Fatal Outcome; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000276:immunology; D006461:Hemolysis / Q000187:drug effects; D006801:Humans
D000906:Antibodies; D002511:Cephalosporins; D002443:Ceftriaxone